Eureka-AI is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Eureka AI

1959 results about "Calcium EDTA" patented technology

Short answer. Calcium Disodium EDTA (Ethylenediaminetetraacetic Acid) is a chemical chelating agent found in many household foods and beverages. Research shows that in addition to the short-term side effects, the chemical may build up in the body, causing significant toxicity after long-term use.

Deposition of calcium-phosphate (CaP) and calcium-phosphate with bone morphogenic protein (CaP+BMP) coatings on metallic and polymeric surfaces

The invention is a medical implantable device which is coated by the method according to the invention. The surface of the substrate used for the implantable device, in the raw condition, following a cleaning regime and physiochemical pretreatments, is coated using a biomimetic process in a supersaturated calcium phosphate solution (SCPS) to obtain the desired coating coverage and morphology maintaining a ratio of calcium to phosphorus pH, as well as solution temperature plays a major role in yielding precipitation of the proper phase of CaP so that composition, morphologies, crystal structures, and solubility characteristics are optimal for the deposition process. The biomimetic coating adds the attribute of osteoconductivity to the implant device. To maximize bone growth, the implant must also induce bone growth, or possess the attribute of osteoinductivity. This attribute is acquired by the use of therapeutic agents, i.e. bone morphogenic proteins (BMP), growth factors, stem cells, etc. The preparation of the SCPS solution is slightly altered so that during the immersion of the implant in the SCPS, the therapeutic agents are co-precipitated and bonded with the CaP directly on the underlying surface of the implant device. A final dipping process into a BMP solution provides an initial burst of cellular activity. For delivering stem and/or progenitor cell, after drying the dipped solution of BMP, the cells are cultured on the surface of the implant.

Strontium fortified calcium nano-and microparticle compositions and methods of making and using thereof

Compositions containing strontium fortified calcium nanoparticles and/or microparticles, and methods of making and using thereof are described herein. The strontium fortified calcium compounds contain calcium ions, calcium atoms, strontium ions, strontium atoms, and combinations thereof and one or more anions. Exemplary anions include, but are not limited to, citrate, phosphate, carbonate, and combinations thereof. The particles can be formulated for enteral or parenteral administration by incorporating the particles into a pharmaceutically carrier. The compositions can further contain one or more active agents useful for bone diseases or disorders, such as vitamin D, growth factors, and combinations thereof. The compositions can be used to treat or prevent one or more bone diseases or disorders of the bone, such as osteoporosis. Alternatively, the particles can be coated onto a substrate, such as the surface of an implant. The coatings can be used to improved biocompatibility of the implant, prevent loosening of the implant, reducing leaching of metal ions from metallic implants, and reduce corrosion. The coatings can be applied to the substrate using a variety of techniques well known in the art. In one embodiment, the coating is applied using electrophoretic deposition. The use of nano- and/or microparticles that provide high surface area helps to improve interfacial strength between the coating and the implant, which allows for the use of lower sintering temperatures. Lowering sintering temperatures minimizes or prevents thermal decomposition of the coating material and/or degradation of the implant material.

Composition used in scale-inhibition corrosion inhibitor, scale-inhibition corrosion inhibitor, and application thereof

ActiveCN103253777AHigh calcium and alkali toleranceGood scale and corrosion inhibitionScale removal and water softeningHigh concentrationTungstate
The invention discloses a composition used in a scale-inhibition corrosion inhibitor, a scale-inhibition corrosion inhibitor, and an application thereof. The composition used in the scale-inhibition corrosion inhibitor comprises cyclodextrin and/or a cyclodextrin derivative, a carboxylic-acid-group-containing homopolymer, a sulfonic-acid-group-containing copolymer, and selectively hydroxycarboxylic acid with a weight ratio of 1:0.2-20:0.04-15:0.2-30:0-20. The scale-inhibition corrosion inhibitor provided by the invention is environment-friendly. According to the invention, the application of phosphorus-containing compound or non-renewable molybdate or tungstate is prevented, such that the scale-inhibition corrosion inhibitor is phosphorus-free and nitrogen-free. The scale-inhibition corrosion inhibitor has high tolerance to calcium and alkali, resistance to corrosion of high-concentration chloride ion and sulfate ion, and wide applicability to water quality. Therefore, technical condition is provided for operation of circulation water under high concentration multiple and for reducing sewage discharge. The scale-inhibition corrosion inhibitor provided by the invention has excellent scale inhibition and corrosion inhibition performances in circulation water system application. With the scale-inhibition corrosion inhibitor, a dose is low, scale-inhibition treatment process is simple and substantial effect is provided. The scale-inhibition corrosion inhibitor is suitable for popularization.

Small molecule polypeptide Ca-chelate of fishbone and preparation method

InactiveCN102406176AHigh calcium chelation rateIncreased bioabsorptionFood preparationSolubilitySide effect
The invention discloses small molecule polypeptide Ca-chelate of fishbone, which belongs to the field of functional food or additive. The method for preparing the small molecule polypeptide Ca-chelate of the fishbone comprises the following steps: boiling the fishbone at high temperature and high pressure; pulping to obtain the fishbone paste; utilizing the compound protease to execute enzymolysis; centrifuging to obtain the liquid supernatant and the sediment; filtering the liquid supernatant to obtain the small molecule polypeptide liquid of the fishbone; executing the composite acid acidification through citric acid and lactic acid for the sediment so as to obtain the fishbone calcium liquid; mixing the small molecule polypeptide liquid of the fishbone with the fishbone calcium liquid; executing the chelation at 40-50 degrees centigrade while the pH value is 7.5-8.5; and drying to obtain the small molecule polypeptide Ca-chelate of the fishbone. The invention has high Ca-chelate rate which reaches over 90%, and has high biological absorption rate of the calcium which reaches over 70%. The invention has no side effects, has good flavor, can be directly absorbed from intestinal mucosa after being eaten, solves the problems that the solubility of the traditional calcium source is bad, the absorption rate is low and the side effect is large, and solves the problem of producing calculi. In addition, the invention has a simple preparation method and low cost.

Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof

The invention discloses a formula milk powder for promoting the absorption of fatty acid and calcium and a preparation method thereof. Raw cow milk, lactose, 1,3-Dioleoyl 2-palmitoyl triglyceride and demineralized whey powder as main materials are added with concentrated whey albumen powder, Alpha-lactalbumin powder, oligosaccharide, walnut oil, casein phosphopeptide, docosahexaenoic acid, arachidonic acid, nucleotide, lutein, inositol, carnitine and the like as well as vitamins, mineral substances and other nutrients needed for strengthening infants, and fat humanization, protein humanization and carbohydrate humanization are realized. The powdery product is produced by the processes of blending, homogenization, concentration, spray-drying, packaging and the like. According to the physiological characteristics and nutritional demand of the infants, the invention reinforces the calcium, the 1,3-Dioleoyl 2-palmitoyl triglyceride, other nutrient ingredients and the like, and aiming at the oversea clinical test conclusion of the 1,3-Dioleoyl 2-palmitoyl triglyceride, the final test conclusion of comparison with breast milk and infant formula milk powder sold on the market in the process of a clinical feeding test is that the feeding result of the designed formula approximates the feeding result of the breast milk and is better than the feeding result of an infant formula milk powder group sold on the market.

Calcium supplementing and calcium locking health care food and preparation method thereof

The invention provides a calcium supplementing and calcium locking health care food. The calcium supplementing and calcium locking health care food comprises calcium, colostrum basic protein, chondroitin sulfate, D-glucosamine, vitamin D, casein phosphopeptides and the like, wherein the colostrum basic protein is obtained by degreasing, separating, concentrating, removing casein, alpha-lactoalbumin, beta-lactoglobulin and substances with molecular weights of more than 30 kDa and less than 1 kDa and drying at a low temperature; the biggest difference between the calcium supplementing and calcium locking health care food prepared by the method provided by the invention and the prior art is that the capacity of the bone tissue in actively absorbing osteoblast nutrition like calcium, ossein and the like can be effectively improved and effects of activating osteoblasts and inhibiting osteoclast activity to enhance bone mineral density and length and promote the health of the bone are obtained. The calcium supplementing and calcium locking health care food provided by the invention, which is a latest generation of domestic osteoarthrosis rehabilitation product, obtains breakthrough in the calcium supplementing effect, can be also used for helping the bone to preferably absorb the calcium in the food, has no toxic and side effect after being taken for a long time.

Preparation method of protein short peptide chelated calcium

The invention provides a preparation method of protein short peptide chelated calcium. The method includes the steps of: refinement treatment and sterilization of mixed raw material containing protein and water, a first hydrolysis by adding proteolytic enzyme, ultrafiltration of the liquid portion separated after the first hydrolysis using a ultrafilter membrane whose retention molecular weight is in the range of 1000-6000 Da, mixing of the macro-molecule peptide liquid which does not permeate the ultrafilter membrane and the solid phase portion separated by the first hydrolysis, a second hydrolysis by adding proteolytic enzyme, purification of micromolecule oligopeptide liquid after twice hydrolysis ultrafiltrations, chelating by adding calcium hydrate or calcium chloride, complete reaction of quantitive sodium carbonate when the pH valve is neutral, filtering for removing deposition, desalination by the nanofiltration membrane, sterilization, condensation and obtaining of the protein short peptide chelated calcium product. The preparation method can substantially improve the protein short peptide obtaining rate and the raw material protein utilization rate, and reduce production cost, so the obtained protein short peptide chelated calcium product has a good quality and high production safety.

Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate

ActiveUS20090068285A1Promotes bone formationMinimize and prevent bone resorptionBiocideInorganic phosphorous active ingredientsDiseaseAntioxidant
The present invention provides novel biomaterials comprising one or more of Mg, Zn and F ions in a carbonate-containing biphasic calcium phosphate (BCP) system. The biomaterial may contain Mg, Zn, F, Mg and Zn, Mg and F, Zn and F, or Mg, Zn and F. The biomaterial may be substantially similar in composition to bone mineral (a carbonate apatite). The biomaterial may feature slow release of Mg, Zn, F, Ca, and P ions. The biphasic calcium phosphate, BCP, may be a mixture of unsubstituted hydroxyapatite (HA) and unsubstituted .-TCP, Ca3(PO4)2. BCP of varying HA/.-TCP ratios may be produced by sintering calcium-deficient apatite, for instance having a Ca/P<1.5, 1.6, 1.67, 1.75 or 1.8 that has been prepared either by a precipitation or by a hydrolysis method or by a solid-state reaction. The amount of each component (by weight %) present in the biomaterials may be as follows: Mg 0.5 to 12 wt %, Zn 1 to 12 wt %, F 0.1 to 4 wt %, calcium 20 to 40 wt %, phosphate 10 to 20 wt %, and carbonate (CO3) 1 to 20 wt %. The biomaterial may further comprise one or more other ion such as strontium, manganese, copper, boron or silicate, or one or more other organic moiety such as a protein, a peptide, or a nutraceutical which may provide antioxidant, anti-bacterial or anti-inflammatory properties. The invention also provides methods of inhibiting bone resorption, methods of treating osteoporosis or delaying the onset of osteoporosis, methods of treating a bone fracture, and methods of inhibiting osteoclast activity. Further, the invention provides methods of treating or reversing bone deficiencies such as bone loss, similar to osteoporosis, caused all or in part by a mineral deficient diet, a disease such as cancer or osteopenia, a treatment such as steroid therapy or radiation therapy, or a physical condition such as immobilization.

Fishbone bioactive polypeptide calcium powder and preparation method

InactiveCN101731666AGuaranteed FeaturesIncreased bioabsorptionFood preparationFood additiveFood grade
The invention discloses fishbone bioactive polypeptide calcium powder and a preparation method, belonging to the field of functional food or food additives. The preparation method comprises the following steps: freezing fishbone, coarse grinding, fine grinding, adding water, stirring, adding a compound protease to hydrolyze, centrifugating, and respectively collecting the supernatant and the precipitate; ultrafiltering the supernatant by a filter membrane, concentrating the filtrate, and freeze-drying to obtain the fishbone protein polypeptide powder; washing the precipitate, drying and pulverizing; activating by using citric acid, and drying to obtain the soluble calcium; and mixing the fishbone protein polypeptide powder and the soluble calcium to obtain the fishbone bioactive polypeptide calcium powder. The fishbone bioactive polypeptide calcium powder enables the biological absorptivity of calcium to reach above 65%, and meanwhile, maintains the functional characteristics of polypeptide. Hydrolysis is carried out by using the food-grade protease, and thus, the fishbone bioactive polypeptide calcium powder has the advantages of high safety and no side effect. The method of the invention has the advantages of simple and feasible realization, and low cost. The fishbone bioactive polypeptide calcium powder can be used as a food additive or directly eaten as nutritional food.
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products